Why is Ishita Drugs falling/rising?

As of 04-Jul, Ishita Drugs & Industries Ltd is experiencing a decline in its stock price, currently at Rs 80.00, which reflects a decrease of 4.0 (-4.76%). The stock has underperformed its sector by 5.27% today and has fallen after two consecutive days of gains. It touched an intraday low of Rs 79.99 and has seen a decrease in delivery volume by 7.95% compared to the 5-day average. Over the past week, the stock has decreased by 2.62%, while it has shown a modest increase of 0.08% over the past month. Despite a strong annual return of 19.87%, the stock's long-term fundamentals appear weak, with a low average Return on Equity (ROE) of 8.34% and stagnant sales growth.
Broader Market Context: In comparison to the benchmark Sensex, which has seen a slight decline of 0.74% over the past week, Ishita Drugs' performance is notably worse. The stock's year-to-date performance is down 13.45%, contrasting sharply with the Sensex's gain of 6.77%. This underperformance, coupled with weak long-term growth indicators and a poor EBIT to Interest ratio, suggests that investor confidence may be waning, contributing to the stock's current downward trend.